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Abstract
Background. Irrational medicine use including excessive use and abuse of antibiotics remains a
crucial problem for the healthcare systems. < In this regard, studies examining approaches to
improving the clinical use of medicines are highly important. Aim: to assess the efficacy rate of
management for the rational use of antibiotics in surgical departments of a multi-disciplinary
hospital. Material and methods. The intervention complex combined the research, educational,
and methodological activities: local protocols for perioperative antibiotic prophylaxis (PABP) for
various surgical departments were developed; local PABP protocols were discussed with the
physicians of specialized surgical departments; official order on implementation of PABP was
issued; the list of drug prescriptions for registration of the first pre-operative antibiotic dose was
changed; audit and feedback processes were introduced as well as consultations of a clinical
pharmacologist were implemented. We assessed the efficacy rate of the interventions basing on
the changes in consumption of antibiotics (both quantitatively and qualitatively) at surgical
departments of a hospital using ATC/DDD methodology. Comparison of the studied outcomes
was performed before and after the intervention implementation and between the departments
(vascular  and  abdominal  surgery).  The  consumption  of  antibacterial  agents  (ATCJ01)  was
measured as a number of defined daily doses (DDD) per 100 bed-days (DDD/100 bed-days,
indicator recommended by the World Health Organization, WHO) and DDD per 100 treated
patients (DDD/100 treated patients). Results. From 2006 to 2012, a decrease in antibacterial
consumption in  surgical  departments  by 188 DDD/100 treated patients  was observed.  We
obtained the opposite results when using an indicator of DDD/100 bed-days (increase by 2.5
DDD/100 bed-days) which could be explained by the dependence on indices of overall hospital
work  and  its  changes  during  the  examined  period.  Observed  changes  in  antibacterial
consumption varied in different surgical departments. The most pronounced positive changes
were noted in the department of vascular surgery: decrease in total antibacterial consumption
by 298 DDD/100 treated patients, decrease in the use of cephalosporins of the III generation
from 141 to 38 DDD/100 treated patients. These positive changes were accompanied by the
same (low) level of consumption/use of reserve antibiotics. In the department of abdominal
surgery, there was no decrease in total antibiotic consumption, as well as in consumption of
broad-spectrum cephalosporins of the III generation and fluoroquinolones, and we observed an
increase in  the use of  reserve antibiotics  (carbapenems) during the study period.  Positive
changes  in  antibiotic  consumption  were  associated  with  the  positive  attitude  of  the
manager/head of the department towards interventions: we observed the most pronounced
decrease in antibiotic consumption straight after the publication of the administrative order on
perioperative antibacterial prophylaxis. Conclusion. The combination of scientific, educational,
and methodological interventions is effective for improving antibiotic application. The study
results provide the rationale for analyzing the drug consumption using the DDD/100 treated
patients measure in addition to the WHO-recommended indicator of DDD/100 bed-days which
depends on overall hospital performance.
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